Liposomes, as nanoscale vesicles composed of a phospholipid bilayer, are widely used in biomedicine, food, and other fields due to their excellent biocompatibility and drug loading capacity. In the preparation process, homogenization technology is a crucial step determining the quality of liposomes, directly affecting their particle size distribution, stability, and functional effects, making it an indispensable core technology in liposome preparation.
Homogenization technology achieves the refinement and homogenization of liposomes through physical processes. Its core principle utilizes the synergistic effect of shear force, cavitation effect, and collision effect. In a high-pressure homogenizer, a coarse lipid suspension is pressurized and passed at high speed through a narrow slit. Large-diameter liposomes break down under strong shear force, while the cavitation effect generated by instantaneous depressurization further refines the particles. Ultimately, uniform dispersion is achieved through particle collisions. Compared to traditional preparation methods, homogenization effectively solves the problems of uneven liposome particle size and wide distribution, promoting the transformation of liposomes from the micrometer to the nanometer scale, meeting the requirements of precision applications such as intravenous injection.

The value of homogenization technology in liposome preparation lies not only in particle size control but also in the comprehensive optimization of product quality. Homogenized liposomes have a more regular and compact bilayer membrane structure, reducing instability caused by membrane defects and significantly lowering the leakage rate of encapsulated drugs. Simultaneously, homogenization equipment can precisely control parameters such as pressure, temperature, and cycle number, ensuring consistency in key indicators such as particle size and encapsulation efficiency across different batches of liposomes. This provides quality assurance for large-scale production and meets the requirements of Good Manufacturing Practices (GMP) for pharmaceuticals.
Optimizing homogenization parameters is the core of achieving precise control in liposome preparation. Practice shows that homogenization pressure and cycle number directly affect liposome properties. Increasing pressure can effectively reduce particle size, but excessive pressure may damage the active ingredient. Multiple cycles can improve homogenization, but the effect slows down after exceeding a critical number of cycles. Furthermore, lipid composition and cholesterol content also affect homogenization results, requiring parameter adjustments based on the specific formulation. For example, when encapsulating heat-sensitive ingredients, a temperature control system is needed to prevent high temperatures during homogenization from damaging the ingredient's activity.
Homogenization technology, through precise particle size control and quality optimization, provides crucial support for the efficient preparation of liposomes. With continuous technological advancements, homogenization processes will further promote the application of liposomes in drug delivery, functional foods, and other fields, injecting momentum into the high-quality development of related industries.